$IDRA Headlines Six stocks to watch 4:27 p.m. Feb. 26,

New Post Public Reply Private Reply Replies (0) Message Board

Mar 18, 2014 at 10:26 AM

$IDRA Headlines

Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
Bears chip away at the S&P 1,775 support 12:01 p.m. Feb. 3, 2014 - Michael Ashbaugh
Charting a bullish early-2014 outlook 1:05 p.m. Dec. 31, 2013 - Michael Ashbaugh
Charting a bullish early-2014 outlook 12:39 p.m. Dec. 31, 2013 - Michael Ashbaugh
S&P, Nasdaq rally from major support 12:09 p.m. Dec. 16, 2013 - Michael Ashbaugh
Pfizer, Affymetrix weigh on drug stocks 3:04 p.m. July 7, 2011 - Val Brickates Kennedy
Idera tumbles 14% on drug setback 2:52 p.m. July 7, 2011 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 5:37 p.m. Jan. 19, 2010 - MarketWatch
Incyte, Idera move on Novartis deals 3:02 p.m. Nov. 25, 2009 - Val Brickates Kennedy
Novartis terminates pact with Idera 9:28 a.m. Nov. 25, 2009 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 5:29 p.m. Dec. 26, 2007 - MarketWatch
Idera Pharmaceuticals' president, Karr, resigns 10:08 a.m. Dec. 26, 2007 - Robert Daniel
Idera Pharma President Karr resigns, stays on board 10:03 a.m. Dec. 26, 2007 - Robert Daniel
Idera signs agonist licensing, collaboration with Merck KGaA 8:10 a.m. Dec. 19, 2007 - Sarah Turner
Idera to get up to $381 mln in milestones 8:03 a.m. Dec. 19, 2007 - Steve Goldstein
Idera, Merck KGaA agree collaboration deal 8:02 a.m. Dec. 19, 2007 - Steve Goldstein
Wednesday's biggest stock gainers and decliners 7:03 p.m. Feb. 28, 2007 - Michael Baron
Idera Pharma started at buy at Merriman Curhan Ford 9:54 a.m. Feb. 7, 2007 - Tomi Kilgore
Drug stocks slip; Nuvelo, Neopharm shares plunge on trial results 5:37 p.m. Dec. 11, 2006 - Carolyn Pritchard

Idera: A Compelling Biotech Pick For March 11:34 a.m. March 7, 2014 - Seeking Alpha
3 Small Cap Biotechs With Near-Term Catalysts 10:25 a.m. March 6, 2014 - Seeking Alpha
Interesting IDRA Put And Call Options For April 19th 12:01 p.m. Feb. 26, 2014 - TheStreet.com
Idera Pharmaceuticals (IDRA) Showing Signs Of Perilous Reversal Today 10:53 a.m. Feb. 24, 2014 - TheStreet.com
Idera Pharmaceuticals: Set To Ride A 200% Gain In 2014 10:38 a.m. Jan. 31, 2014 - Seeking Alpha
Idera Pharmaceuticals Presents a Promising Opportunity 3:23 p.m. Dec. 26, 2013 - Wall St. Cheat Sheet
Friday’s Biggest Stock Losers: INSY OPK, and More 8:52 a.m. Dec. 13, 2013 - InvestorPlace.com
9 Biotechnology Stocks to Buy Now 7:00 a.m. Dec. 11, 2013 - InvestorPlace.com
10-Q: IDERA PHARMACEUTICALS, INC. 8:02 a.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
Biotech-Focused Baker Bros. Accumulates These 3 Stocks 9:55 a.m. Oct. 1, 2013 - Seeking Alpha
Idera Phase 2 Data Provides For Exciting Q4 2013 And Q1 2014 9:02 a.m. Sept. 25, 2013 - Seeking Alpha
Analysts: Blackstone Mortgage Gaining Traction and 3 Other Research Notes to Browse 2:37 p.m. Aug. 29, 2013 - Wall St. Cheat Sheet
Idera Enters Agreement with NCI to Evaluate Use of TLR Antagonists for Treatment of Genetically Defined Lymphomas 7:39 a.m. Aug. 29, 2013 - benzinga.com
Idera Announces Issuance of US Patent Covering IMO-8400, Lead Candidate in Phase 2 Trial 7:05 a.m. July 18, 2013 - benzinga.com
Idera Pharma to Issue Positive Phase I Trial Results on TLR Antagonist IMO-8400 6:31 a.m. June 21, 2013 - benzinga.com
Idera Pharmaceuticals Announces Initiation of a Phase 2 Trial of IMO-8400 in Patients with Moderate to Severe Plaque Psoriasis 7:07 a.m. June 5, 2013 - benzinga.com
10-Q: IDERA PHARMACEUTICALS, INC. 7:49 a.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
Idera Pharmaceuticals Announces Closing of Common Share Offering 3:19 p.m. May 7, 2013 - benzinga.com
Idera Pharmaceuticals Prices 17.5M Share Offering at $0.50/Share 4:59 a.m. May 2, 2013 - benzinga.com
1 Stock to Buy, 1 Stock to Short: Penny Stocks 9:52 a.m. April 16, 2013 - InvestorPlace.com

Idera Pharmaceuticals Reports Fourth Quarter and Year End 2013 Financial Results and Provides Corporate Update 7:51 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Expansion of Pipeline into Two Orphan Autoimmune Diseases 7:35 a.m. March 13, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Appointment of Julian Baker and Dr. Kelvin Neu to its Board of Directors 8:31 a.m. March 12, 2014 - BusinessWire - BZX
Idera to Host Conference Call and Webcast to Report Fourth Quarter and Full Year 2013 Financial Results on Thursday, March 13, 2014 9:31 a.m. March 6, 2014 - BusinessWire - BZX
Idera to Present at the Cowen & Co. 34th Annual Health Care Conference 9:31 a.m. Feb. 26, 2014 - BusinessWire - BZX
Idera to Present at the 2014 RBC Capital Markets’ Global Healthcare Conference 5:02 p.m. Feb. 18, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 5:15 p.m. Feb. 10, 2014 - BusinessWire - BZX
Idera to Present at 16th Annual BIO CEO & Investor Conference 9:30 a.m. Feb. 6, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stockand Pre-Funded Warrants 10:10 a.m. Feb. 5, 2014 - BusinessWire - BZX
Idera Pharmaceuticals Announces Public Offering of Common Stock and Pre-Funded Warrants 5:01 p.m. Feb. 4, 2014 - BusinessWire - BZX
Idera Announces Publication of New Data Demonstrating Impact of Inhibiting TLRs 7, 8, and 9 in a Preclinical Model of Autoimmune Disease 9:01 a.m. Jan. 22, 2014 - BusinessWire - BZX
Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine 9:00 a.m. Jan. 9, 2014 - PR Newswire
Idera Expands Leadership Team and Strengthens Clinical Development Expertise in Oncology and Orphan Diseases 9:00 a.m. Jan. 9, 2014 - BusinessWire
Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera 9:00 a.m. Dec. 31, 2013 - PR Newswire
Senior Appointments, Stock Splits, New Guidelines, Positive Results, and Clinical Trial Updates - Research Report on Receptos, MEDNAX, CombiMatrix, Anacor, and Idera 9:00 a.m. Dec. 10, 2013 - PR Newswire
Idera Pharmaceuticals Opens Enrollment for Phase 1/2 Clinical Trial of IMO-8400 in Waldenstrom's Macroglobulinemia 8:30 a.m. Dec. 4, 2013 - BusinessWire
Idera Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 5:02 p.m. Nov. 25, 2013 - BusinessWire
Idera Pharmaceuticals Reports Third Quarter 2013 Financial Results and Provides Corporate Update 8:45 a.m. Nov. 14, 2013 - BusinessWire
Idera Pharmaceuticals to Host Conference Call to Report Third Quarter 2013 Financial Results on Thursday, November 14, 2013 5:10 p.m. Nov. 7, 2013 - BusinessWire
Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants 4:14 p.m. Sept. 30, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mather Promotes Connection with Free Gardening Kits

Winter Loneliness No Match for Mather’s Green Thumb Initiative Here's something heartfelt coming out of the Windy City: gardening kits. This ain't your standard Wall Street babble—it's about a nonprofit called Mather trying to shed some light on the colder months by giving seniors in Illinois a damn good reason to be joyfully busy. No boilersuit and tie needed, just a...

American Water's NARUC 2026 Role: Insight and Influence

American Water Steers the Utility Ship at NARUC Ah, a classic move by American Water—rolling up to the 2026 NARUC Annual Meeting & Education Conference with guns blazing. They picked San Juan, Puerto Rico, as their battleground from November 8-11. Now, I know what you're thinking: a bit of sun, a bit of talk, but don’t let the sweet location fool you. It’s a...

Bankers Brace for Rising Costs, Falling Loan Demand

Tough Roads Ahead for Bankers? Picture this: bankers everywhere are gripping their coffee mugs a little tighter these days. Why? They’re staring down the barrel of rising funding costs, and loan demand looking about as flat as a pancake. IntraFi, a fintech handshake where finance folks swap tales, did a bit of number-crunching, and it's not paintin' a pretty picture....

Budget Airlines' Woes Reveal Travel Insurance Pitfalls

A Turbulent Ride for Travelers Man, it seems like the skies aren't so friendly nowadays, especially if you've got your hard-earned dollars wrapped up in a flight with a budget airline like Spirit or JetBlue. Here's the latest scoop: JetBlue's finances are under the microscope, and if you're planning to fly with them, you better become a travel insurance expert pronto. The...

Curaleaf Secures Key Approvals in Aurora Acquisition Bid

Curaleaf Gets a Green Light for Acquisition Talk about maneuvering a minefield, eh? Curaleaf Holdings just stamped out the last of its paperwork in the cutthroat cannabis industry to acquire Aurora Cannabis. We're looking at the final sign-offs from not one, but two major players: Germany and Canada's competition authorities. That's no small feat when you're trying to...

Membrane's USDM1 Integration: A Game-Changer?

Fresh Bonds Meet Digital Rails In the ever-changing landscape of institutional finance, innovation comes wrapped in unexpected packages, and this time it's got a digital bow on it. Membrane Labs and M1X Global recently announced the integration of USDM1, a snazzy USD-denominated sovereign bond, right into Membrane's established institutional credit and lending...

Small-Town Firm Rises to CNBC's Top 100 Advisors

Defying Odds from a Small Town Let's talk about McKinley Carter Wealth Services snagging a spot on CNBC's 2026 Financial Advisor 100. Being the lone ranger from West Virginia in a sea of over 41,000 advisory firms ain't no small potatoes. That's right, this Wheeling-based firm landed at No. 98, solidifying its place amongst the top independent financial advisors in the...

Millrose Properties Faces Class Action Deadline Amid Turmoil

Millrose Properties: Legal Storm Brewing If you've got stock in Millrose Properties, Inc. (NYSE:MRP), you might want to listen up. There's a class action lawsuit in the works that could have quite the impact. Investors have until December 8, 2026, to throw their hat in the ring and maybe even lead the charge on this lawsuit. The Allegations Up Close Let's break down what...

Greenberg Traurig Secures Top Honors at LBA Awards

A Celebration of Achievements in South Florida Nothing signifies success like a room full of applause and a shiny award, especially when it comes from a community as influential as South Florida's construction scene. This past October, Greenberg Traurig, a heavy hitter in the legal sphere, clinched its title as the Law Firm of the Year from the Latin Builders Association...

Creative Solutions Joins FICO Marketplace, Boosts AI Edge

Creative Solutions and FICO Unite Well, we're diving into some strategic magic today. Creative Solutions International, not just your average marketing agency, has just hopped onto the FICO Marketplace platform. The word on the street is they're shaking things up with their Collections Marketing Platform. It's like giving your old financial letters a whole AI-driven paint...